Skip to main content
. Author manuscript; available in PMC: 2026 Apr 30.
Published in final edited form as: Clin Cancer Res. 2026 Apr 15;32(8):1383–1388. doi: 10.1158/1078-0432.CCR-25-3609

Figure 1. Kaplan-Meier Plot of Event-Free Survival in NIAGARA.

Figure 1.

Source: FDA generated

D = Durvalumab; G = Gemcitabine; C = Cisplatin

Note: Figure adapted from the label; there are no restrictions on its use